Ravulizumab: Solution concentrate for I.V. infusion 300 mg in 3 mL vial, Solution concentrate for I.V. infusion 1.1 g in 11 mL vial; Ultomiris® - March 2023 – July 2023 PBAC Meeting Page last updated: 27 October 2023 Public Summary Document (PSD) March 2023 July 2023 PBAC Meeting - (PDF 887KB) Public Summary Document (PSD) March 2023 July 2023 PBAC Meeting - (Word 224KB)